Recovery and Results After hormone therapy, you can enjoy benefits such as improved libido, mood, and sleep quality
This dual-receptor approach enhances insulin secretion, promotes fat metabolism, and may deliver more comprehensive metabolic benefits than GLP-1 activation alone
Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (under the brand name Mounjaro) and chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity (under the brand name Zepbound)
GLUCAGON RECEPTOR Glucagon receptor activity is being studied for its role in energy balance and metabolism
Samms RJ, Sloop KW, Gribble FM, et al
Long-term sustainability depends on habits developed during the research period